131 Followers on Owler
Mersana is a Massachusetts-based biopharmaceutical company that researches and develops antibody-drug conjugates for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights
Mersana is a Massachusetts-based biopharmaceutical company that researches and develops antibody-drug conjugates for the treatment of cancer... Read more
Mersana Therapeutics President & CEO: Martin Huber

President & CEO

Martin Huber

CEO Approval Rating

82/100

2001

PublicAcquisition Pending from Day One Biopharmaceuticals, Inc.NASDAQMRSN

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology

Annual Revenue
$33.2M
Employees
150
Funding
$289.1M

News

Acquisition
Nov 13, 2025
GlobeNewswire
Mersana Therapeutics Was acquired by Day One Biopharmaceuticals, Inc. for $285M

Mersana Therapeutics Competitors

1Daiichi Sankyo
2ImmunoGen
3Gilead Sciences
4CytomX
5Igenica
6AnaptysBio
7ADC Therapeutics
8Paragon Gene
9ADC Bio
10Meditope
Unlock 19 + competitors

Trending Companies